Skip to main content
Shailender Bhatia, MD, Oncology, Seattle, WA

ShailenderBhatiaMD

Oncology • Seattle, WA

Melanoma

Professor, Medical Oncology, University of Washington/Fred Hutchinson Cancer Center

Join to view full profile

Dr. Bhatia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bhatia's full profile

Already have an account?

  • Office

    825 Eastlake Ave E
    Mailstop CE2-112
    Seattle, WA 98109
    Phone+1 206-606-7222

Summary

  • Dr. Shailender Bhatia is a medical oncologist in Seattle, WA and is affiliated with University of Washington (UW), and Fred Hutchinson Cancer Center (FHCC.) He serves as the Clinical and Clinical Research Director of the Melanoma and Renal Cancer Program at FHCC. Dr Bhatia received his medical degree from All India Institute of Medical Sciences (AIIMS) and subsequently completed hematology-oncology training at UW/FHCC. He has been practicing oncology for >15 years. He specializes in skin cancers (including melanoma and Merkel cell carcinoma) and has led numerous cutting-edge clinical trials of immunotherapy in skin cancers, many of which led to FDA-approval of new agents. He has more than 100 publications, which have over 20,000 citations.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2005 - 2008
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2001 - 2004
  • All India Institute of Medical Sciences
    All India Institute of Medical SciencesClass of 2000

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2004 - 2025
  • CT State Medical License
    CT State Medical License 2004 - 2005
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Fred Hutch Phase 1 Program Director, Dr. John Thompson, Retires
    Fred Hutch Phase 1 Program Director, Dr. John Thompson, RetiresDecember 19th, 2024
  • Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in Uganda
    Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
  • Merck Could Keep Its Patent Edge by Shifting Keytruda Cancer Drug to a Simple Shot
    Merck Could Keep Its Patent Edge by Shifting Keytruda Cancer Drug to a Simple ShotDecember 2nd, 2022
  • Join now to see all

Professional Memberships

Dr. Shailender Bhatia, Dr. Shailender Bhatia, MD, Dr. S Bhatia